Korean Centers and Cancer Types

Korea has operating proton programs at Samsung Medical Center and the National Cancer Center, and carbon-ion treatment at Yonsei Cancer Center / Severance Hospital. The table shows the hospitals’ published cancer programs by modality. APIS helps identify relevant hospitals for review using the cancer type, prior treatment and available records.

Hospitals, Treatment Types and Cancer Programs

Use this table to see which hospital and treatment type may be relevant to your cancer.

Korean hospital Treatment type Published cancer programs and examples Program status Sources / dates
Yonsei Cancer Center / Severance Hospital Carbon-ion Prostate, liver, pancreas and lung cancers; difficult-to-operate non-squamous head-and-neck cancers including Adenoid Cystic Carcinoma (ACC); sarcomas; locally recurrent rectal cancer. Operating carbon-ion program. [1] August 19, 2026 expansion notice; current program page.
Samsung Medical Center Proton Pediatric, brain, skull-base and spinal tumors; head-and-neck cancer including ACC; lung, liver, pancreas, prostate, breast, esophageal and selected gynecologic cancers and sarcomas. Operating proton program. The exact diagnosis and prior treatment guide review. [2][6][7] Official program pages; undated.
National Cancer Center Proton Pediatric / brain / spinal tumors, chordoma, head-and-neck, lung, liver, pancreas, prostate, esophageal, breast, cervical and ocular cancers. Published examples include recurrent rectal cancer and sacral chordoma. Operating proton program. ACC-specific acceptance requires confirmation. [3][4][5][8] Official program pages and case examples; undated.

A published indication describes the hospital’s program. The hospital reviews the patient’s full case before offering treatment.

ACC · Pelvic / Sacral Sarcoma · Recurrent Rectal Cancer · Locally Advanced Pancreatic Cancer (LAPC) provide cancer-specific review questions beyond this program table.

Planned Facilities and Future Capacity

  • SNUH Gijang Heavy Ion Therapy Center, Busan: The hospital’s project page targets opening and treatment in the second half of 2027.
  • National Cancer Center additional proton system: Additional-system project; a clinical start date needs separate confirmation.
  • Keimyung University Dongsan, Daegu: Hospital cancer-center information states a 2029 proton start.
  • Seoul St. Mary’s Hospital: The November 26, 2025 hospital announcement targets first operation at the end of 2029.
  • Asan Medical Center: Hospital information describes carbon-ion introduction for 2031.

Equipment installation, a building opening and the first clinical treatment are different milestones. Confirm the current hospital status before making a treatment plan.

SNUH and Asan provide general oncology care, but their announced carbon-ion projects are future facilities. They are not listed as operating particle-treatment options in the current indications table. SNUH project status · Asan construction update, June 12, 2026.

Find a Relevant Hospital Review

APIS can help identify which published programs are relevant to your diagnosis.

Sources and dates
  1. Yonsei Cancer Center / Severance Hospital, August 19, 2026. Current carbon-ion program expansion.Current Yonsei carbon-ion program
  2. Samsung Medical Center: conditions treated; ACC / head and neck details.
  3. National Cancer Center: target diseases.
  4. National Cancer Center: cancers treated and clinical examples.
  5. National Cancer Center: Korean proton indications.
  6. Samsung Medical Center: brain, skull-base and spinal tumors.
  7. Samsung Medical Center: pediatric proton therapy. Undated
  8. National Cancer Center: pediatric proton therapy. Undated
  9. Samsung Medical Center Proton Therapy Center.
  10. SNUH Gijang project information. Hospital target
  11. Dongsan Cancer Healing Center. Published 2029 plan
  12. Catholic Medical Center, November 26, 2025. Seoul St. Mary’s plan.
  13. Asan Medical Center, November 4, 2025. 2031 carbon-ion project.

Content reviewed October 23, 2026.

Your request has been received.
We will review the submitted information and contact you by email if additional details are required.​